EQS-News: Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
EQS-News: Marinomed Biotech AG / Key word(s): Expansion
Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry
into the Compounding Market
11.05.2026 / 11:09 CET/CEST
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for
Entry into the Compounding Market
• Strategic Commercial Milestone: Marinomed has chosen its first product
for the!-->…